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Abstract
In clinical trials, mixed effects models for repeated measures (MMRM) and pattern
mixture models (PMM) are often used to analyze longitudinal continuous outcomes.
We describe a simple missing data imputation algorithm for the MMRM that can be
easily implemented in standard statistical software packages such as SAS PROC MI.
We explore the relationship of the missing data distribution in the control-based and
delta-adjusted PMMs with that in the MMRM, and suggest an efficient imputation
algorithm for these PMMs. The unobserved values in PMMs can be imputed by
subtracting the mean difference in the posterior predictive distributions of missing
data from the imputed values in MMRM. We also suggest a modification of the copy
reference imputation procedure to avoid the possibility that after dropout, subjects
from the active treatment arm will have better mean response trajectory than subjects
who stay on the active treatment. The proposed methods are illustrated by the
analysis of an antidepressant trial.
Keywords: Control-based imputation; Delta-adjusted imputation; Missing not at random;
Mixed effects model for repeated measures
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1 Introduction
Missing data are unavoidable in clinical trials, and can potentially result in biased treat-
ment effect estimates. The primary analysis generally assumes a missing at random (MAR)
mechanism. Suppose two subjects are identical (same treatment, same historical outcome)
until a certain time point, and subject A discontinues from the study after that time point,
but subject B remains on the treatment. The MAR mechanism implies that the future sta-
tistical behaviors of the two subjects are expected to be the same. This assumption may be
unrealistic in some applications. For example, in a trial investigating a symptomatic treat-
ment, the treatment benefit may disappear rapidly after discontinuation of the treatment,
and dropouts and completers are unlikely to have the same statistical behaviors.
Recent regulatory guidelines (ICH E9, 1999; CHMP, 2010; National Research Council,
2010) emphasize the importance of sensitivity analyses to assess the robustness of the trial
result under the missing not at random (MNAR) assumption. The pattern-mixture models
(PMM) have become increasingly popular in sensitivity analyses for handling longitudinal
clinical data with nonignorable missingness because the underlying missing data assump-
tions are easy to understand and interpret (Lu, 2014a). Two types of PMMs commonly
used as MNAR sensitivity analyses in confirmatory trials are the control-based and delta-
adjusted PMMs (Little and Yau, 1996; Carpenter et al., 2013; Ratitch et al., 2013). These
PMMs provide de facto (effectiveness) estimands of the treatment effect, which measure
the effect of the drug as actually taken using all randomized subjects under the intent to
treat (ITT) principle (Carpenter et al., 2013; Ayele et al., 2014). Recently an addendum to
ICH E9 was proposed relating to estimands and sensitivity analyses, and an expert group
meeting sponsored by Statisticians in the Pharmaceutical Industry (PSI) was devoted to
this topic prior to the release of the addendum (Phillips et al., 2016). The estimands from
PMMs and MMRM correspond respectively to estimands 2 and 3 illustrated at the meeting
(Phillips et al., 2016). These PMMs assume that the benefit among subjects in the active
arm disappears or diminishes after treatment discontinuation, and therefore generally yield
more conservative treatment effect estimates than the MMRM.
PMMs are often implemented via multiple imputation (MI). The simplest imputation
algorithm is the sequential regression imputation (SRI) for monotone data, i.e. no miss-
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ing data prior to dropout (Little and Yau, 1996; Ratitch et al., 2013; Lu, 2014a). Tang
(2015, 2016) proposed Markov chain Monte Carlo (MCMC) algorithms via monotone data
augmentation (MDA) for missing data imputations in mixed effects models for repeated
measures (MMRM) and a class of PMMs that assume the same observed data distribution
as the MMRM. The MDA algorithm is a collapsed Gibbs sampler (Liu, 1994), in which the
missing data yim2 ’s after dropout are integrated out from the posterior distribution, and
only the intermittent missing data ym1 are imputed in the imputation I-step. Compared
to a full data augmentation (FDA) algorithm that imputes both yim1 ’s and yim2 ’s in the
I-step, the MDA algorithm generally converges to the same stationary distribution faster
with smaller autocorrelation between posterior samples (Schafer, 1997; Tang, 2016).
The purpose of the paper is to propose a method that enables readers to write simple
and efficient computer code for missing data imputations in the MMRM, control-based
PMMs and delta-adjusted PMMs by building on existing software packages (e.g. PROC
MI in SAS, Norm package in R) that provide missing data imputation for incomplete
multivariate normal data. The proposed method will produce the same posterior predictive
distribution for the missing data as Tang (2015, 2016) MDA algorithm.
Our algorithm involves four steps, and details will be explained later in this section.
1. Construct a prior p(φx,φy) = p(φx)p(φy) that can easily be specified in the software,
where φx and φy are parameters associated respectively with the distributions of the
covariates x˜i and outcomes yi.
2. Impute missing data for MMRM (it assumes MAR) under the prior p(φx,φy) using
the software by pretending wi = (x˜
′
i,y
′
i)
′ is normally distributed.
3. Calculate the difference in the posterior mean of the missing data in MMRM and
PMMs. It is a function of the posterior sample of φy.
4. Subtracting the difference from the MAR-based imputation yields the imputed values
for PMMs.
Section 2 describes the imputation algorithm for MMRM (i.e. steps 1 and 2). Let
f(yi|x˜i,φy) and f(yio|x˜i,φy) denote respectively the conditional distributions of the com-
plete outcome yi and observed outcome yio given the covariates x˜i in the MMRM, and p(φy)
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the prior. The missing values in the MMRM are imputed by pretending wi = (x˜
′
i,y
′
i)
′ fol-
lows a joint multivariate normal distribution with density f(wi|φx,φy) = f(yi|x˜i,φy)f(x˜i|φx).
But it does not require x˜i to be normally distributed or continuous (that is, f(x˜i|φx) is
not the true density for x˜i). Since φx and φy have independent prior distributions, the
marginal distribution of the posterior samples φy in this new algorithm will converge to its
target distribution f(φy|(x˜i,yio)
′s) ∝ p(φy)
∏
i f(yio|x˜i,φy).
Section 3 describes the imputation algorithm for control-based and delta-adjusted PMMs
(i.e. steps 3 and 4). These PMMs assume the same observed data distribution as the
MMRM. Therefore the posterior distributions of φy in these PMMs are the same as that
in MMRM (Tang, 2016). Furthermore, the missing data after dropout are assumed to be
normally distributed with the same covariance matrix as that in MMRM. Thus the miss-
ing values in PMMs can be imputed by subtracting the mean difference from the imputed
values in the MMRM.
In the copy reference (CR) PMM, it is possible that the mean response after dropout
among drug-treated subjects could be better than that among subjects who remain on the
active treatment. We propose a modification of the CR procedure in Section 3.
Section 4 illustrates the proposed methods by the analysis of an antidepressant trial.
Section 5 will compare the proposed imputation algorithm with some existing methods.
2 MCMC algorithms for MMRM
2.1 MMRM and related MCMC algorithms
We consider a two-arm trial, where n subjects are randomly assigned to the active (gi = 1)
or control (gi = 0) treatment. Let yi = (yi1, . . . , yip)
′ denote the outcomes at the p post-
baseline visits, and (xi1, . . . , xid)
′ the baseline covariates for subject i. We assume that xik’s
are fully observed. In general, yi’s will be only partially observed. Let ri index the dropout
pattern for subject i according to the last observation. A subject is in pattern ri = s if s
is last visit that the subject has a measurement observed, and ri = 0 if a subject has no
post-baseline assessment. Without loss of generality, we sort the data so that subjects in
pattern s are arranged before subjects in pattern t if s > t. Suppose after filling in the
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intermittent missing data, yik is not missing in the first nk subjects.
Let yio, yim1 and yim2 denote respectively the observed data, intermittent missing data,
and missing data after dropout for subject i. Let ~yit = (yi1, . . . , yit). Then yio (yim1)
is the observed (missing) part of ~yiri. Let xi0 ≡ 1, x˜i = (xi1, . . . , xid, gi)
′ and xi =
(xi0, . . . , xid, gi)
′. Let Yo, Ym1 , Ym2, and X denote respectively the observed outcomes,
intermittent missing data, missing data after dropout, and covariates from all subjects.
The following MMRM is often used as the primary analysis for longitudinal outcomes
collected at a fixed number of time points (Siddiqui et al., 2009). It assumes MAR.
yi = (yi1, . . . , yip)
′ ∼ N [(α′1xi, . . . ,α
′
pxi)
′,Σ] (1)
where q = d + 2, and αj = (αj0, . . . , αjd, δj)
′ be a q × 1 vector of the covariate and treat-
ment effects at visit j. The model includes an unstructured treatment × visit interaction
effect, and thus allows the direct estimate of the treatment effect at each scheduled visit
(Siddiqui et al., 2009). The within subject errors are modeled by an unstructured covari-
ance.
Let Σ = U−1 Λ(U ′)−1 be the LDL decomposition of Σ, where Λ = diag(γ−11 , . . . , γ
−1
p ),
and U =


1 0 . . . 0
−β21 1 . . . 0
. . . . . . 0
−βp1 . . . −βp,p−1 1

. Then (1) can be written as Uyi ∼ N [(α
′
1xi, . . . ,α
′
pxi)
′,Λ],
or equivalently as the product of the following regression models
yij|~yi,j−1,xi ∼ N
(
θ′jzi,j−1, γ
−1
j
)
for j ≤ p, (2)
where αj = (αj0, . . . , αjd, δj)
′ = αj −
∑j−1
t=1 βjtαt, βj = (βj1, . . . , βjj−1)
′, θj = (α
′
j,β
′
j)
′,
and zij = (x
′
i, ~y
′
ij)
′. Let α = (α1, . . . ,αp)
′.
Tang (2015) considered a conjugate normal-inverse-Wishart (NIW) prior for (Σ,α).
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That is, Σ ∼ W−1(A, ν0), vec(α)|Σ ∼ N(vec(α0),M
+ ⊗ Σ), and the prior density is
p(α,Σ) ∝p(Σ)p(α|Σ) ∝
{
|Σ|−
ν0+p+1
2 exp
[
−
1
2
tr(AΣ−1)
]}
{
|Σ|−
r
2 exp
[
−
1
2
(vec(α−α0))
′(M ⊗ Σ−1)(vec(α−α0))
]}
,
(3)
where W−1(A, ν0) denotes an inverse-Wishart distribution with ν0 degrees of freedom, and
p× p scale matrix A, α0 is a p× q fixed matrix containing the prior mean of α, and M
+
is Moore-Penrose inverse of a q × q fixed matrix M = (mij) with rank r. The prior for
q − r covariates is flat. If a covariate has a flat prior, the corresponding mean components
in α0 and (co)variance elements in M will be set to 0. For example, suppose historical
information is available only on the placebo response, and there is no baseline covariate
(d = 0). We may put a (weakly) informative prior on the intercept, and a flat prior on the
treatment effect. Then M =

m11 0
0 0

 and α0 = (α01, 0p), where 0k is a k × 1 vector of
zeros. If the prior is flat on all covariates (r = 0), then M = 0. We need to pre-specify
A, ν0, α0 and M in the prior. For Jeffrey’s prior p(α,Σ) ∝ |Σ|
−(p+1)/2, we have ν0 = 0,
A = 0, α0 = 0, and M = 0. We do not require A to be positive definite.
Tang (2015, 2016) developed the MDA (called MDA-T) and FDA (called FDA-T) al-
gorithms for MMRM. They rely on the fact that (θj, γj)’s are independent in the posterior
distribution given the augmented monotone (Yo, Ym1) or complete (Yo, Ym1, Ym2) data since
the corresponding likelihood can be factored as the product of p independent likelihoods for
(θj, γj)’s based on (2), and the prior for (α,Σ) can be factored into independent densities
for (θj, γj)’s. The MDA algorithm is generally recommended in real applications because
it converges to the same stationary distribution faster than the FDA algorithm (Schafer,
1997; Tang, 2016). Appendix A.1 provides a brief review of the two algorithms.
2.2 MCMC algorithm for MMRM using SAS PROC MI
This section describes a simple method to implement Bayesian MMRM analysis in a soft-
ware package that can generate multiple imputations for incomplete multivariate normal
data. We illustrate the method using SAS PROC MI since SAS is more commonly used
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to analyze clinical trials in the pharmaceutical industry. The underlying idea is to run a
Bayesian analysis for wi = (x˜
′
i,y
′
i)
′ by pretending wi follows a multivariate normal distri-
bution wi
i.i.d
∼ N(αw,Σw), where αw =

αx
αy

 and Σw =

Σxx Σ′yx
Σyx Σyy

. The likelihood for
(αw,Σw) can be decomposed as independent likelihoods for (αx,Σxx) and (α,Σ),
n∏
i=1
f(wi;αw,Σw) = {
n∏
i=1
f(x˜i;αx,Σxx)}{
n∏
i=1
f(yi|xi;α,Σ)}.
The method yields the same posterior distribution of (α,Σ) as any valid MCMC algorithm
for (1) if the prior for (αw,Σw) can be factored into independent densities as p(αw,Σw) =
p(αx,Σxx)p(α,Σ), where p(α,Σ) is defined in (3). We assume x˜i’s are fully observed, but
x˜i may not be normally distributed.
For missing data imputation, it is convenient to reparameterize (αw,Σw) based on the
LDL decomposition of Σw = U
−1
w Λw(U
′
w)
−1, where Uw is a lower triangular matrix with
all 1’s on the diagonal, and Λw = diag(γ
∗−1
1 , . . . , γ
∗−1
q−1+p). Let −β
∗
j denote the first j − 1
elements of row j in Uw, α
∗
j the j-th element of αw = Uwαw, and θ
∗
j = (α
∗
j ,β
∗
j )
′. Note that
(θ∗j+q−1, γ
∗
j+q−1) has the same interpretation as (θj, γj) defined in (2). Then (αx,Σxx) can
be expressed a function of φx = {(θ
∗
j , γ
∗
j ) : j = 1, . . . , q − 1}, and (α,Σ) is a function of
φy = {(θ
∗
j , γ
∗
j ) : j = q, . . . , q + p− 1} = {(θj , γj) : j = 1, . . . , p}.
Lemma 1 below provides the theoretical basis for the proposed algorithm, in which a
NIW prior is constructed for (αw,Σw). Its proof will be deferred to Appendix A.2. One
needs to create the following quantities from A, ν0, α0 and M to define the NIW prior.
• m11 is (1, 1) entry of M =

m11 M12
M21 M22

. Note that m+11 = m−111 if m11 > 0, and
m+11 = 0 if m11 = 0.
• Aw =

 M∗ M∗α∗0′
α∗0M
∗ A+α∗0M
∗α∗0
′

, where α∗0 is a p× (q− 1) matrix containing the last
q−1 columns of α0, M
∗ =M22 if m11 = 0, and M
∗ =M22−M21M12/m11 if m11 > 0.
• νw = ν0 + r − (q − 1) if m11 = 0, and νw = ν0 + r − q if m11 6= 0.
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• αw0 = 0q−1+p if m11 = 0, and αw0 = m
−1
11

M21
M∗1

 if m11 6= 0, where M∗1 = α0

m11
M21

.
In large confirmatory trials, a flat prior is generally put on α (r = 0, M = 0), then we
have Aw =

0 0
0 A

, νw = ν0 − q + 1, m11 = 0 and αw0 = 0q−1+p.
Lemma 1 Suppose in a Bayesian analysis, (αw,Σw) or (αw,Λw) are sampled under the
NIW prior Σw ∼ W
−1(Aw, νw) and αw|Σw ∼ N(αw0, m
+
11Σw) (when m11 = 0, f(αw|Σw) ∝
constant) by pretending wi
i.i.d
∼ N(αw,Σw). Then
(a) (θ∗j , γ
∗
j )’s are independent in the prior, and (θ
∗
j+q−1, γ
∗
j+q−1) has the same prior as
(θj, γj) defined in (17) in Appendix A.1.
(b) (αx,Σxx) and (α,Σ) are independent in the prior.
(c) If (1) holds, but x˜i may not be normally distributed, the posterior distributions of φy
and (α,Σ) are the same as as that from the MCMC algorithms discussed in Section 2.1.
In SAS, MCMC sampling for incomplete multivariate normal data can be conveniently
performed using PROC MI. It is flexible to specify priors in SAS. The prior on αw could
be flat (i.e. m11 = 0, f(αw|Σw) ∝ constant), and Aw may not be of full rank. SAS PROC
MI produces posterior samples of (αw,Σw). One can recreate φy = {(θj, γj) : j = 1, . . . , p}
from (αw,Σw) based on LDL decomposition of Σw, and recreate (α,Σ) from (θj , γj)’s based
on Σ = U−1 Λ(U ′)−1, and α = U−1[α1, . . . ,αp]
′.
SAS PROC MI implements Schafer (1997) MDA algorithm (called MDA-SAS) under
Jeffrey’s prior, and a FDA algorithm (called FDA-SAS) under a general prior. To provide
further insight into the proposed method, we will explain in Appendix A.3 why the two
algorithms in SAS yield the same posterior distribution of φy as the MDA-T and FDA-T
algorithms without the use of Lemma 1.
3 Missing data imputation in PMMs
PMMs are generally implemented via MI. In MI, m (m > 1) complete datasets are im-
puted, and analyzed using a standard method (e.g. MMRM, analysis of covariance model
(ANCOVA)). The results from the m complete datasets are then combined using Rubin
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(1987) rule. One major challenge in the MI inference is the imputation of missing data.
We will introduce a simple and efficient strategy for missing data imputation in a class of
PMMs that assume the same observed data distribution as MMRM.
The joint distribution of (yi, ri) in PMMs can be factored as
f(yi, ri|φ,pi,xi) = f(yi|ri,φy,xi)f(ri|pi,xi)
= f(~yiri|φy,xi)Q(yim2 |~yiri,φy,xi)f(ri|pi,xi),
where f(ri|pi,xi) models the marginal proportions of subjects in each pattern, andQ(yim2 |~yiri,xi,φy)
is the conditional distribution of yim2 given ~yiri = (y
′
io,y
′
im1
)′ and xi. A common feature of
these PMMs is that the outcome ~yiri before dropout has the same marginal distribution as
that defined in (1). That is, the observed data (yio’s) distributions are identical in PMMs
and MMRM, and the intermittent missing data (yim1 ’s) are MAR.
In PMMs, the complete data likelihood can be written as
{
n∏
i=1
f(~yiri|xi,φy)
n∏
i=1
Q(yim2 |~yiri,xi,φy)
}{
n∏
i=1
f(ri|xi,pi)
}
.
If the prior φy ∼ p(φy) is the same as specified in section 2, and an independent prior is
put on pi, then pi and (φy, Ym1, Ym2) are independent in the posterior distribution, and the
joint posterior distribution of (φy, Ym1 , Ym2) is given by
pos2(φy, Ym1 , Ym2|Yo, X) ∝ pos1(φy, Ym1 |Yo, X)
n∏
i=1
Q(yim2 |~yiri,xi,φy), (4)
where pos1(φy, Ym1 |Yo, X) ∝ p(φy)
∏n
i=1 f(~yiri|xi,φy). In both MMRM and PMMs, the
posterior distribution of (φy, Ym1) is pos1(φy, Ym1 |Yo, X).
We propose the following two-step procedure for imputing missing data from their pos-
terior predictive distribution in PMMs
1. Sample (φy, Ym1) from the marginal posterior distribution pos1(φy, Ym1|Yo, X) using
an algorithm described in Section 2;
2. Impute yim2 from Q(yim2 |~yiri,xi,φy) for i = 1, . . . , n.
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Because step 1 of the algorithm does not depend on step 2, it is equivalent to running
step 1 until convergence, and then sampling yim2 ’s from Q(yim2 |~yiri,xi,φy). The proposed
approach is not necessarily a MCMC algorithm. For example, we may run step 1 via a
FDA approach under MAR, and then run step 2 to impute yim2’s in PMMs. However, the
joint distribution of (φy, Ym1, Ym2) will converge to the target distribution (4).
Suppose the joint distribution of yi = (~y
′
is,y
′
im2)
′ is normal with mean (η′is,η
′
im)
′ and
covariance Σ =

Σ11s Σ′21s
Σ21s Σ22s

 in pattern s. The conditional distribution Q(yim2 |~yiri,xi,φy)
of yim2 given ~yiri is (Carpenter et al., 2013)
yim2 |~yis, ri = s ∼ N [ηim + Σ21sΣ
−1
11s(~yis − ηis),Σ22s − Σ21sΣ
−1
11sΣ
′
21s ]. (5)
Because all models assume the same observed data distribution and a common covariance
matrix var(yi) = Σ across patterns, the missing data distribution Q(yim2 |~yiri,xi,φy) in
these models differs only in ηim. Therefore, the imputed values in PMMs can be obtained
by subtracting the difference in mean yim2 from the imputed values in MMRM while the
imputation for MMRM can be done using SAS PROC MI. All models assume MAR in the
control arm, and hence have the same imputed values among control subjects.
For the purpose of missing data imputation, it is more convenient to express the condi-
tional distribution Q(yim2|~yiri,xi,φy) in terms of the LDL decomposition of Σ. Suppose
U and Λ can be partitioned as U =

U11s 0
U21s U22s

, and Λ = diag(Λ1s,Λ2s) according to the
outcomes before and after dropout in pattern s. That is, the dimensions of U11s , and Λ1s
are all s× s. Let L = U−1 =

L11s 0
L21s L22s

. Then Σ21sΣ−111s = −U−122sU21s = −L22sU21s , and
Σ2.1s = Σ22s − Σ21sΣ
−1
11sΣ
′
21s = L22sΛ2sL
′
22s . In pattern s = 0, Σ2.1s = Σ22s = Σ, U22s = U ,
and L22s = L. Then (5) becomes
yim2 |~yis, ri = s ∼ N [ηim − L22sU21s(~yis − ηis), L22sΛ2sL
′
22s ]. (6)
Below we briefly describe the assumption on missing data in each model. A summary
of the assumptions in all models is provided in Table 1. The assumption can be formulated
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Assumption on missing data after dropout
Marginal E(yij |~yij−1,xi) Conditional mean Mean
Method mean of yim2
(a) j > s (b) of yim2 given (~yis,xi)
(c,d) Difference (f)
MMRM (MAR) µi2s + δ2sg ϑij + δj g µ
MAR = µCR + L22sδ2sg 0
Controlled Imputation
J2R µi2s - µ
MAR − δ2sg −δ2sg
CIR µi2s + δs1p−sg - µ
MAR + (δs1p−s − δ2s)g (δs1p−s − δ2s)g
CR - ϑij µ
MAR − L22sδ2sg −L22sδ2sg
ECR - ϑij + (1− φ)δj g µ
MAR − φL22sδ2sg −φL22sδ2sg
MCR - ϑij + djδj g µ
MAR − L22s∆
MCR
s g −L22s∆
MCR
s g
Delta-adjusted Imputation
conditional - ϑij + (δj −∆
c
sj
) g µMAR − L22s∆
c
s g −L22s∆
c
s g
unconditional µi2s + (δ2s −∆
u
s )g - µ
MAR −∆us g −∆
u
s g
Table 1: Missing data distribution in pattern s for various models: (a) the mean of ~yis is µi1s + δ1sg,
and the variance of yi is Σ in all models. In pattern s = 0, δs = 0;
(b) ϑij = µij +
∑j−1
t=1 βjtyit. The
conditional variance of yij given (~yij−1,xi) is γ
−1
j .
(c) the conditional variance of yim2 given (~yis,xi) is
Σ2.1s = L22sΛ2sL
′
22s ;
(d) µCR = L22s(µi2s − U21s~yis). In pattern s = 0, U21s~yis = 0;
(f) Difference in
mean of yim2 between PMM and MMRM.
based either on the marginal distribution of yim2 or on the conditional distribution of yij
given the historical outcome. The following notations are used. Suppose subject i is in
pattern ri = s (s < p), treatment group gi = g. Let ei be a p−s vector of standard normal
random variables. Let µij =
∑d
k=0 αjkxik denote the mean of subject i at visit j if the sub-
ject was on the control treatment, µi1s = (µi1, . . . , µis)
′, and µi2s = (µi,s+1, . . . , µip)
′. Let
µ
ij
= µij −
∑j−1
t=1 βjtµit =
∑d
k=0 αjkxik, and µi2s = (µi,s+1, . . . , µip)
′. Let δ1s = (δ1, . . . , δs)
′,
δ2s = (δs+1, . . . , δp)
′, δ1s = (δ1, . . . , δs)
′ and δ2s = (δs+1, . . . , δp)
′.
a. MMRM (MAR)
The MMRM assumes dropouts have the same mean response trajectory as completers
with identical historical outcome and covariates. By (6),
yim2 |~yis,xi, ri = s ∼ N(µ
MAR,Σ2.1s), where U21s ~yis = 0 at s = 0, and
µMAR = µi2s + δ2sgi − L22sU21s(~yis − µi1s − δ1sgi) = L22s(µi2s + δ2s gi − U21s~yis). Thus
yim2 can be generated in matrix form as
yMARim2 = L22s(µi2s + δ2s gi − U21s ~yis + Λ
1/2
2s ei), (7)
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or sequentially from the following regression model
yij|~yij−1,xi ∼ N
[
µ
ij
+
j−1∑
t=1
βjtyit + δj gi, γ
−1
j
]
for j > s. (8)
Throughout the paper, the model parameters in the missing data distribution (e.g. (7)
and (8)) are evaluated at the values randomly drawn from their posterior distribution,
and in SRI (e.g. (8)), the imputed values at previous visits will be used as predictors for
imputing the missing values at the next visit.
b. Control-based Imputation
The control-based imputation assumes that the statistical behavior of active subjects
after dropout is similar to that of control subjects, and it reflects the fact that subjects
generally no longer receive the active treatment after dropout. Carpenter et al. (2013)
proposed three control-based PMMs: jump to reference (J2R), copy increment in reference
(CIR), and CR. These PMMs are suitable for placebo controlled trials and studies where
the control treatment consists of a standard-of-care treatment, and subjects discontinued
from the active arm tend to switch to standard-of-care (Ratitch et al., 2013). Lu (2014b)
considered an extension of the CR approach, which uses a sensitivity parameter to
capture the gradual departure from the MAR mechanism. We also suggest a modification
of the CR procedure to avoid the possibility that dropouts from the active arm have
better mean response trajectory than subjects who remain on the active treatment.
b.1. Jump to Reference (J2R)
In J2R, once the active subjects cease the treatment, their mean response jumps to that
of the control subjects. It essentially assumes that immediately upon withdrawal from the
active group, all benefit from the treatment is gone (Mallinckrodt et al., 2013). The mean
response is µi1s + δ1sgi before dropout, and µi2s after dropout. The conditional
distribution of yim2 given (~yis,xi) is N(µ
J2R,Σ2.1s), where
µJ2R = µi2s − L22sU21s(~yis − µi1s − δ1sgi) = µ
MAR − δ2sgi for subjects in pattern s. Thus
yim2 can be generated as
yJ2Rim2 = y
MAR
im2 − δ2sgi.
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b.2. Copy Increment in Reference (CIR)
The CIR assumes that the mean profile of active subjects after dropout is parallel to that
of control subjects. The mean response is µi1s + δ1sgi before dropout, and µi2s + δs1p−sgi
after dropout, where 1k is a k × 1 vector of ones. The conditional distribution of yim2
given (~yis,xi) is N(µ
CIR,Σ2.1s), where µ
CIR = µMAR + (δs1p−s − δ2s)gi for subjects in
pattern s, and δs = 0 at s = 0 since there is no difference due to treatment in mean
baseline response between two arms. We can impute yim2 using
yCIRim2 = y
J2R
im2
+ δs1p−sgi = y
MAR
im2
+ (δs1p−s − δ2s)gi.
b.3 Copy Reference (CR)
In CR, the conditional distribution of yim2 given (~yiri,xi) among dropouts in the active
arm is the same as that of control subjects. That is, yim2 |~yis,xi, ri = s ∼ N(µ
CR,Σ2.1s),
where µCR = L22s(µi2s − U21s ~yis) = µ
MAR − L22sδ2s gi. Thus yim2 can be imputed as
yCRim2 = y
MAR
im2
− L22sδ2s gi.
The missing data after dropout in both arms can also be imputed sequentially from
yij|~yij−1,xi, ri = s ∼ N
[
µ
ij
+
j−1∑
t=1
βjtyit, γ
−1
j
]
for j > s, (9)
which is identical to the zero-dose model of Little and Yau (1996). The method is called
copy reference possibly because the missing data distribution is still N(µCR,Σ2.1s) if
active subjects are assumed to have the same mean response profiles as the reference (i.e.
control) subjects both before and after dropout (Carpenter et al., 2013).
A variant of the CR procedure is implemented in SAS (version 9.4), in which the
imputation model is built using only data from the control arm (Ratitch and O’Kelly,
2011; Ayele et al., 2014). Although Lu (2014a) showed that two variants of CR performed
similarly in a simulation study, the use of only control data may lead to larger random
noise in the imputed outcomes if the sample size is small in the control arm.
b.4. Extension of Copy Reference (ECR)
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Lu (2014b) considered an extension of the zero-dose or CR model, which assumes
yij|~yij−1,xi, ri = s ∼ N
[
µ
ij
+ (1− φ)δj gi +
j−1∑
t=1
βjtyit, γ
−1
j
]
for j > s, (10)
where φ ∈ [0, 1] is a pre-specified sensitivity parameter that characterizes the gradual
deviation from the MAR mechanism, with φ = 0 corresponding to MAR with the full
benefit of the active treatment, and φ = 1 corresponding to the zero-dose model. The
dropout missing data can be imputed from (10) or equivalently from
yECRim2 = y
MAR
im2 − φL22sδ2s gi.
b.5. A Modification of Copy Reference (MCR)
Below we illustrate a potential issue with CR using a simple example. Suppose there are
only two post-baseline visits (p = 2), and the treatment effects are positive (δ1 > 0 and
δ2 > 0) at both visits (assuming higher scores represent improvement), but δ2 is negative.
The mean yi2 is
∑d
k=0 α2jxij + β21E(yi1) + δ2 among active subjects who complete the
study, and
∑d
k=0 α2jxij + β21E(yi1) among active subjects who discontinue after the first
visit. In CR, the dropouts have better mean response at visit 2 than completers.
We propose a simple modification of the CR procedure. Let dj = 0 if δˆj δˆp ≥ 0, and 1
otherwise, where δˆj and δˆp are the (restricted) maximum likelihood estimates (MLE) from
(1). Since the true parameters are unknown, dj’s are determined based on the MLE from
(1) prior to the imputation. In MCR, the missing value can be imputed sequentially from
yij|~yij−1,xi ∼ N
[
µ
ij
+ djδj gi +
j−1∑
t=1
βjtyit, γ
−1
j
]
, (11)
or equivalently in matrix form from
yMCRim2 = y
MAR
im2
− L22s∆
MCR
s gi, (12)
where ∆MCRs = ((1− ds+1)δs+1, . . . , (1− dp)δp)
′. The MCR procedure is identical to the
CR procedure if d1 = . . . = dp = 0.
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c. Delta-adjusted imputation
In the delta-adjusted PMMs, subjects who discontinue from the active treatment will
have their unobserved outcome worse by some pre-specified amount compared with
subjects who continue the treatment (Ratitch et al., 2013). The adjustment could be
applied in either conditional or unconditional ways.
c.1. Conditional delta-adjusted imputation
In the conditional approach, the missing data after dropout in pattern s can be imputed
sequentially from the following regression model
yij|~yij−1,xi ∼ N
[
µ
ij
+ (δj −∆
c
sj
) gi +
j−1∑
t=1
βjtyit, γ
−1
j
]
, (13)
where ∆csj ’s are the pre-fixed amount of adjustment at visit j > s for the active subjects
in pattern s. There are two popular ways to specify ∆csj ’s (Ratitch et al., 2013;
Mallinckrodt et al., 2013). The adjustment can be applied only once at the first visit after
dropout (i.e. ∆csj = ∆ when j = s + 1, and 0 if j > s+ 1), or applied to all visits after
dropout (i.e. ∆csj = ∆ when s+ 1 ≤ j ≤ p). The two adjustment strategies correspond
respectively to variant-1 and variant-2 described in Ratitch et al. (2013).
By (13), the conditional distribution of yim2 given (~yis,xi) is N(µ
cDEL,Σ2.1s), where
∆cs = (∆
c
ss+1, . . . ,∆
c
sp)
′ and µcDEL = L22s [µi2s + (δ2s −∆
c
s) gi − U21s ~yis]. The missing data
after dropout can be imputed from (13) or equivalently from
ycDELim2 = y
MAR
im2
− L22s∆
c
s gi. (14)
c.2. Unconditional delta-adjusted imputation
The unconditional approach corresponds to variant-3 of Ratitch et al. (2013). The
adjustment is made by simply subtracting a constant from the MAR-based imputation
yuDELim2 = y
MAR
im2
−∆us gi, (15)
where ∆us = (∆
u
ss+1
, . . . ,∆usp)
′ is a vector of pre-specified constants. Unlike the conditional
approach in which the adjustment at earlier visits will affect subsequent visits, the
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adjustments at different visits are unrelated in the unconditional approach.
4 A numerical example
We analyze an antidepressant clinical trial reported in Mallinckrodt et al. (2013). The
Hamilton 17-item rating scale for depression is collected at baseline and weeks 1, 2, 4, 6.
The dataset consists of 84 active subjects, and 88 placebo subjects. The dropout rate is
24% (20/84) in the active arm, and 26% (23/88) in the placebo arm.
The primary endpoint is the change from baseline in Hamilton depression score, and
the explanatory variables are intercept, baseline Hamilton score, and treatment status
(p = 4, q = 3). We analyze the data using both frequentist and Bayesian approaches. In
the frequentist approach, the MMRM analysis is fit using SAS PROC MIXED. It includes
the treatment×visit and baseline×visit interactions as the fixed effects, and an
unstructured covariance matrix is used to model the within-patient errors. Our model is
different from that used in Mallinckrodt et al. (2013) in that we do not include the
investigative site as a covariate. In the Bayesian analysis, we consider three MCMC
schemes: the MDA-T algorithm under the prior f(α,Σ) ∝ |Σ|−(p+3)/2 (i.e. ν0 = 2), and
the MDA-SAS and FDA-SAS algorithms under Jeffrey’s prior f(αw,Σw) ∝ |Σw|
−(p+q)/2.
By Lemma 1, the three MCMC schemes yield the same posterior distribution of (α,Σ).
The latter two analyses are conducted using SAS PROC MI. As shown in Table 2, the
treatment effects from the three Bayesian analyses and the likelihood-based analysis are
similar since the prior is non-informative.
Bayesian analysisa
Week Proc Mixed MDA-T MDA-SAS FDA-SASb
1 0.092 [−1.256, 1.439] 0.092 [−1.251, 1.436] 0.091 [−1.267, 1.446] 0.096 [−1.245, 1.462]
2 −1.403 [−3.228, 0.422] −1.404 [−3.230, 0.434] −1.402 [−3.221, 0.430] −1.395 [−3.200, 0.440]
4 −2.225 [−4.201,−0.248] −2.219 [−4.209,−0.235] −2.229 [−4.213,−0.233] −2.220 [−4.191,−0.251]
6 −2.802 [−5.008,−0.596] −2.793 [−5.004,−0.587] −2.803 [−5.016,−0.586] −2.795 [−5.012,−0.557]
Table 2: Estimated treatment effect [95% confidence or credible interval] in an antidepressant trial: a
posterior mean and quantile-based credible interval are evaluated based on 40, 000MCMC samples collected
from every 100-th iteration after a “burn-in” period of 10, 000 iterations; b In FDA-SAS, Jeffrey’s prior can
be specified with the PRIOR=INPUT= option (adjusted for 1 df in the prior) or PRIOR=JEFFREYS
option, and both options produce identical output.
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We also analyze the data using various PMMs, where m = 10, 000 posterior samples
are collected from the MDA-SAS algorithm, and the complete datasets are imputed using
the strategy in Section 3. Table 3 displays the treatment effect estimate ± standard error
(SE) in MMRM and various PMMs. Under MAR, the MI-based and likelihood-based
analyses yield very close results. At week 1, there is no missing data, and the treatment
effect estimates are identical in all approaches. In weeks 2, 4, and 6, the PMMs generally
yield smaller treatment effect estimate than the MMRM. The MCR and CR produce the
same result since δˆj δˆ4 ≥ 0 at j ≥ 2, and yi1’s are observed for all subjects although
δˆ1δˆ4 < 0. The sample SAS code is provided in the supplementary materials.
Method Week 1 Week 2 Week 4 Week 6
Missing at random
MMRM (ML) 0.092± 0.683 −1.403± 0.924 −2.225± 1.001 −2.802± 1.116
MMRM (MI) 0.092± 0.683 −1.401± 0.925 −2.224± 1.001 −2.806± 1.118
Missing not at random
Control-based imputation
J2R 0.092± 0.683 −1.303± 0.927 −1.927± 1.004 −2.126± 1.130
CIR 0.092± 0.683 −1.296± 0.926 −2.009± 1.001 −2.451± 1.109
CR 0.092± 0.683 −1.297± 0.926 −1.975± 1.001 −2.372± 1.109
ECR: φ = 0.5 0.092± 0.683 −1.349± 0.925 −2.100± 0.999 −2.589± 1.109
MCR 0.092± 0.683 −1.297± 0.926 −1.975± 1.001 −2.372± 1.109
Conditional delta-adjusted imputation
∆cs = (−4, 0, . . . , 0)
′ 0.092± 0.683 −1.122± 0.938 −1.800± 1.009 −2.020± 1.141
∆cs = (−2, . . . ,−2)
′ 0.092± 0.683 −1.261± 0.930 −1.873± 1.010 −2.047± 1.139
Unconditional delta-adjusted imputation
∆us = (−3, . . . ,−3)
′ 0.092± 0.683 −1.192± 0.934 −1.826± 1.010 −2.082± 1.136
Table 3: Estimated treatment effect ± SE by visit in MMRM and various PMMs. PMMs are implemented
via MI based on m = 10, 000 imputations. Posterior samples are collected from every 100-th iteration after
a “burn-in” period of 10, 000 iterations using the MDA-SAS algorithm.
5 Comparison with several existing methods
This section reviews several existing imputation methods. These methods generally
produce similar results to the algorithm proposed in section 3 if they make the same
assumptions on the observed data distribution (i.e. same observed data likelihood), and
the number of imputations is large enough to stabilize the result. The difference in results
is usually small, and it arises because of the use of different priors, and imputation
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variability due to the use of a finite number of imputations.
The main advantages of the proposed algorithm are (1) it sufficiently uses the existing
functions of SAS PROC MI, and the SAS code is simpler and easier to maintain and/or
modify, and (2) the algorithm reaches stationarity quickly particularly if one chooses the
MDA-SAS approach for imputation in MMRM. It is also more convenient to use the
proposed method to compare different PMMs in sensitivity analysis. One can simply save
the imputed datasets for MMRM, and the posterior samples of φy, and then use the
method described in Section 3 to derive the imputed dataset for each PMM.
5.1 Sequential regression imputation (SRI)
The SRI approach (Little and Yau, 1996; Ratitch et al., 2013; Lu, 2014a) is a popular
imputation method for monotone data. It can be viewed as a special case of the MDA-T
algorithm. Under monotone missingness, the MDA-T algorithm involves only the P-step,
and reaches stationary in one step. When A = 0, M = 0 and p(α,Σ) ∝ |Σ|−(ν0+p+1)/2, the
posterior distribution (19) in Appendix A.1 can be expressed as (Tang, 2016)
γj |Ym1, Yo ∼ χ
2
nj+ν0+j−q−p
/Sˆj and θj |γj, Ym1 , Yo ∼ N [θˆj , (γj
nj∑
i=1
z′i,j−1zi,j−1)
−1], (16)
where θˆj = (
∑nj
i=1 z
′
i,j−1zi,j−1)
−1(
∑nj
i=1 z
′
i,j−1yij) and Sˆj =
∑nj
i=1(yij − z
′
i,j−1θˆj)
2. The
missing data after dropout can be sequentially imputed from (8), (9), (10), (11), (13)
respectively for MMRM, CR, ECR, MCR, and conditional delta-adjusted PMM.
In the literature, the SRI approach is mainly applied to models with simple
conditional distribution of yij given ~yij−1. But it is also suitable for complicate PMMs
such as J2R and CIR using the method described in Section 3.
The SRI approach is available in SAS (version 9.4) PROC MI for imputations under
MAR, and the conditional delta-adjusted imputations (using MNAR and MONOTONE
statements). In SAS, the posterior distribution of γj ∼ χ
2
nj−q−(j−1)
/Sˆj is slightly different
from (16) due to the use of a different prior.
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5.2 Ratitch et al. (2013) approach
Ratitch et al. (2013) described a procedure for data with intermittent missing values. It
firstly uses Schafer (1997) MDA algorithm implemented in SAS to impute the
intermittent missing data (Ym1) m times. The SRI approach is then used to impute Ym2
for each imputed monotone dataset. The sampling schemes are different in Ratitch et al.
(2013) method and the proposed algorithm (assume MDA algorithm is used)
• Ratitch et al scheme: Iterate between φx,φy|X, Yo, Ym1 and Ym1|φx,φy, X, Yo until
convergence. Sample φ∗y|X, Ym1, Yo, and Ym2|φ
∗
y, X, Ym1, Yo after convergence.
• Proposed scheme: Iterate between φx,φy|X, Yo, Ym1 and Ym1|φx,φy, X, Yo until
convergence. Sample Ym2|φy, X, Ym1, Yo after convergence.
Compared to Ratitch et al. (2013) method, the proposed scheme avoids one additional
step in sampling φ∗y, and it can save computational time particularly if the number of
imputations m is large, or if one wants to compare different PMMs in sensitivity analysis.
Similarly to SRI, Ratitch et al. (2013) method is developed for the CR and conditional
delta-adjusted imputation, but it can be modified to handle J2R and CIR.
5.3 Macro based on SAS Proc MCMC
Mallinckrodt et al. (2013) developed a SAS package for missing data imputation in
PMMs, and it is freely available at http://www.missingdata.org.uk. The package is based
on SAS PROC MCMC, in which (α,Σ) is sampled using Metropolis-type algorithms.
The convergence of the Metropolis-type algorithm can be slow particularly if the
dimension of parameter space is large (e.g. when the number of post-baseline visits p is
large). The real clinical data are usually monotone or approximately monotone, and the
MDA algorithm generally converges much more quickly with smaller autocorrelation
between posterior samples than the Metropolis-type algorithm. For the antidepressant
trial analyzed in Section 4, the MDA algorithm converges within 100 iterations, and the
lag-1 autocorrelation is close to 0 for all model parameters (Tang, 2016). Furthermore,
our SAS code is much simpler, and runs much faster than Mallinckrodt et al. (2013)
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macro for the same number of MCMC iterations. But Mallinckrodt et al. (2013) macro
can handle more complex MMRM (e.g. covariance matrix heterogeneity).
6 Discussion
The PMMs have been widely used as sensitivity analysis of longitudinal outcomes with
non-ignorable missing data. We describe a novel approach for missing value imputations
in the MMRM, delta-adjusted PMMs and control-based PMMs. The imputed values in
PMMs can be obtained from that under MAR by subtracting the mean difference in their
posterior predictive distributions, which is a function of the posterior samples of the
MMRM model parameters φy. We have focused on the control-based and
delta-adjustment PMMs. However, the imputation algorithm works for any PMMs that
assume the same observed data distribution as MMRM.
For CR, it is possible to impute missing data in an alternative way using SAS PROC
MI. One may firstly impute the intermittent missing data yim1’s under MAR. The
dropout missing data yim2 ’s can be imputed by setting the treatment status as placebo
for dropouts in both arms.
In (1), the covariance matrix is assumed to be homogeneous across all subjects, and
there is a covariate × visit interaction for each covariate, so that the MCMC sampling
can be easily implemented using SAS PROC MI. For more complex MMRMs, one may
use Tang (2016) MDA algorithm or Mallinckrodt et al. (2013) SAS macro.
There is considerable debate regarding the appropriateness of using Rubin’s variance
estimator when the data imputation and analysis models are uncongenial (Meng, 1994).
In control-based PMMs, Rubin’s variance estimator overestimates the variance of the
estimated treatment effect (Lu, 2014a; Ayele et al., 2014). Intuitively, this is because the
data are imputed on an as-treated basis (Little and Yau, 1996), but analyzed under the
ITT principle. In a companion paper, we show that Rubin’s variance estimator is
approximately unbiased in delta-adjusted PMMs, and this provides theoretical support
for the use of delta-adjusted PMMs as MNAR sensitivity analysis in clinical trials.
Imputations under MNAR based on the fully conditional specification (FCS) method
are implemented in SAS (version 9.4). The FCS approach involves specifying the
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conditional distribution for each incomplete variable given the other variables, and
iterating the imputations on a variable-by-variable basis until convergence (van Buuren,
2007). It can be challenging to find the stationary distribution of the missing data in the
FCS approach under MNAR, but it is different from that in the MCMC method since the
intermittent missing data are MAR in the MCMC algorithms (see Section 3), and MNAR
in the FCS approach (this can easily be seen in the special case where all outcomes are
observed except few subjects miss the first visit). Further research shall be done to
understand the FCS imputation under MNAR.
Acknowledgments
We would like to thank the associate editor and referees for their constructive comments
that greatly help to improve the quality of the article.
SUPPLEMENTARY MATERIAL
Sample SAS code for the analysis of the antidepressant trial is provided in the
supplementary materials. The raw dataset is freely available at www.missingdata.org.uk.
A Appendix
A.1 MDA and FDA algorithms for MMRM
Tang (2015, 2016) developed the MDA algorithm (called MDA-T) for MMRM. Compared
to Schafer (1997) MDA algorithm for incomplete multivariate normal data, the new MDA
method allows the use of both non-informative and informative priors, and greatly
reduces the amount of matrix inversion in imputing (yim1,yim2)’s from their posterior
predictive distribution. In addition, the new MDA algorithm can handle more complex
assumptions on the mean and covariance of yi’s.
In the prior, (θj, γj)’s follow independent normal-gamma distributions (Tang, 2015)
f(θj, γj) ∝ γ
ν0+2j+r−p−3
2
j exp
[
−
γj
2
θ˜′j(A˜j +Bj)θ˜j
]
, (17)
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where θ˜j = (−θ
′
j , 1)
′, A˜j is the leading (q + j)× (q + j) submatrix of the (q + p)× (q + p)
matrix A˜ =

0 0
0 A

, Iq is the q × q identity matrix, α¨j = (Iq,α1, . . . ,αj) and
Bj = α¨
′
jMα¨j .
The likelihood function for the augmented monotone data is given by
n∏
i=1
f(yiri|xi,φy) =
p∏
j=1
γ
nj
2
j exp
[
−
γj
2
θ˜′j(
nj∑
i=1
zijz
′
ij)θ˜j
]
. (18)
Combining (17) and (18) yields the posterior distribution for(θj, γj)’s, which is
normal-gamma, and can be generated using the methods of Tang (2016, 2015)
f(θj , γj|Ym1 , Yo, X) ∝ γ
nj+ν0+2j+r−p−3
2
j exp
[
−
γj
2
θ˜′jDj θ˜j
]
, (19)
where Dj = A˜j +Bj +
∑nj
i=1 zijz
′
ij . Tang (2016) derived the posterior distribution of yim1
f(yim1|yio,φy) ∝
ri∏
j=h
exp
[
−
γj(U˜
′
jmyim1 − eij)
2
2
]
∝ N(µˆym1 , Vˆym1), (20)
where h (h < ri) is the index of the first missing observation for subject i, (U˜jm, U˜jo) is a
partition of the (ri − h+ 1)× 1 vector U˜j = (−βjh, . . . ,−βj,j−1, 1, 0, . . . , 0)
′ according to
the missing (yim1) and observed (yioh) parts of (yih, . . . , yiri)
′ for j ≥ h,
eij = α
′
jxi +
∑h−1
t=1 βjtyit − U˜
′
joyioh (U˜
′
jmyim1 − eij = yij −α
′
jxi −
∑j−1
t=1 βjtyit),
Vˆym1 = (
∑ri
j=h γjU˜jmU˜
′
jm)
−1 and µˆym1 = Vˆym1
∑ri
j=h γjeijU˜jm.
The MDA-T algorithm repeats the following I- and P- steps until convergence
P: Draw (θj , γj) from the posterior distribution (19) for j = 1, . . . , p;
I: Impute yim1 ’s from (20) for subjects with intermittent missing data.
Similarly, a FDA algorithm can be developed on basis of the posterior distribution of
(θj, γj) given the augmented full data Yf = {Yo, Ym1 , Ym2}
f(θj, γj|Yf , X) ∝ γ
n+ν0+2j+r−p−3
2
j exp
[
−
γj
2
θ˜′j(A˜j +Bj +
n∑
i=1
zijz
′
ij)θ˜j
]
. (21)
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The algorithm (called FDA-T) repeats the following steps until convergence.
P: Draw (θj , γj) from its posterior distribution (21) for j = 1, . . . , p;
I: Impute yim1 ’s from (20), and yim2 ’s from f(yim2 |~yiri,xi,φy).
A.2 Proof of Lemma 1
Proof Let M¯ =

0 0′
0 M∗

 and M =

m11 M12
M21 M
∗

, where M ∗ =M21M12/m11 if m11 > 0,
and M ∗ = 0 if m11 = 0. Then M¯ +M = M . Let j˜ = q − 1 + j. By Lemma 2 of Tang
(2015), in the prior, (θ∗j , γ
∗
j )’s are independent, and the distribution of (θ
∗
j˜
, γ∗
j˜
) is
f(θ∗
j˜
, γ∗
j˜
) ∝ γ∗
j˜
νw+2(q−1+j)+rw−(q−1+p)−3
2 exp
[
−
γ∗
j˜
2
θ˜∗
′
j˜
(A˜wj +Bwj)θ˜
∗
j˜
]
where A˜w =

 0 0′p˜
0p˜ Aw

 =

 M¯ M¯α0′
α0M¯ A +α0M¯α
′
0

, θ˜∗
j˜
= (−θ∗
′
j˜
, 1)′, uw = (1,α
′
w0)
′,
Bw = m11u
′
wuw, A˜wj and Bwj denote respectively the leading (q + j)× (q + j) submatrix
of Aw and Bw, rw = 1 if m11 > 0, and rw = 0 if m11 = 0. A little algebra shows that
A˜wj = α¨
′
jM¯α¨j + A˜j , Bwj = α¨
′
jMα¨j and A˜wj +Bwj = Bj + A˜j . Thus
f(θ∗
j˜
, γ∗
j˜
) ∝ γ∗
j˜
ν0+2j+r−p−3
2 exp
[
−
γ∗
j˜
2
θ˜∗
′
j˜
(A˜j +Bj)θ˜
∗
j˜
]
, (22)
and (θ∗
j˜
, γ∗
j˜
) has the same prior distribution as (θj, γj) defined in (17).
Since φx and φy are independent in the prior, and the likelihood function can be
factored as the product of
∏n
i=1 f(x˜i|φx) and
∏n
i=1 f(yio|xi,φy), φx and φy are
independent in the posterior distribution. The posterior distribution of φy is
f(φy|Yo, X) ∝
∏n
i=1 f(yio|xi,φy)
∏p
j=1 f(θ
∗
j˜
, γ∗
j˜
), which is identical to that from any valid
MCMC algorithm for (1).
Since (αx,Σxx) is a function of φx, and (α,Σ) is a function of φy, (αx,Σxx) and
(α,Σ) are independent in both the prior and posterior distributions, and the posterior
distribution of (α,Σ) is identical that from any valid MCMC algorithm for (1).
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A.3 MCMC algorithms in SAS
The MDA-SAS algorithm repeats the following steps until the algorithm converges.
P1: Sample (θ∗j , γ
∗
j )’s from f(θ
∗
j , γ
∗
j |X) for j = 1, . . . , q − 1.
P2: Draw (θ∗q−1+j , γ
∗
q−1+j)’s from f(θ
∗
q−1+j, γ
∗
q−1+j|Ym1, Yo, X) for j = 1, . . . , p.
I: Impute missing data yim1 ’s from f(yim1|yio,xi,φy).
The P2 and I steps in the MDA-SAS algorithm are equivalent to the P and I steps in the
MDA-T algorithm, and are unrelated to the P1-step. This explains the equivalence of the
MDA-T and MDA-SAS algorithms.
The FDA-SAS algorithm iterates between the following steps until convergence.
I: Impute missing data yim1 ’s and yim2 ’s;
P: Sample (αw,Σw) from their posterior distribution
Σw|Yf ,X ∼ W
−1
(
n∑
i=1
(wi − w¯)
⊗2 +Aw +
nm11
n+m11
(w¯ −αw0)
⊗2, f
)
,
αw|Σw, Yf ,X ∼ N
(
1
n+m11
(nw¯ +m11αw0),
1
n+m11
Σw
)
,
(23)
where A⊗2 = AA′, w¯ = n−1
∑n
i=1wi, f = n+ νw − 1 if m11 = 0 and f = n + νw if
m11 > 0. The P-steps of the FDA-SAS and FDA-T algorithms seem quite different. If
(αw,Σw) is distributed as (23), (θ
∗
q−1+j , γ
∗
q−1+j) has in fact the same posterior distribution
as (θj, γj) defined (21), and this can be proved using the fact that the random Wishart
matrix can be expressed as a function of independent normal-gamma random variables
(Tang, 2015).
Schafer (1997) obtained (23) under the normal-inverse-Wishart prior (i.e. m11 6= 0).
The proof will be similar when m11 = 0, at which (23) reduces to
Σw|Yf , X ∼ W
−1
(
n∑
i=1
(wi − w¯)
⊗2 + Aw, n+ νw − 1
)
,
αw|Σw, Yf , X ∼ N
(
w¯, n−1Σw
)
.
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SAS (version 9.4) PROC MI uses wrong degrees of freedom (df) f = n + νw when
m11 = 0 (i.e. f(αw|Σw) ∝ constant), and one specifies the prior with the PRIOR
=INPUT= option. One may reduce the df in the prior by 1 (i.e. from νw to νw − 1) in
order to get the right posterior distribution. The df is right in SAS PROC MI if m11 > 0,
or if one specifies Jeffrey’s prior using the PRIOR=Jeffreys option (m11 = 0).
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